In search of developing therapeutic strategies against highly invasive BC in T2DM patients that were associated with high gene expression levels of the ribosomal p70S6K1, we investigated the biological impact of p70S6K1 downregulation and the blockade of its kinase activity on the oncogenic effects of GA on TNBC progression. This evidence concerns the gene RPS6KB1 and breast cancer.